Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma.

Vogel TJ, Dellorusso C, Welcsh P, Shah CA, Goff BA, Garcia RL, Swisher EM.

Transl Oncol. 2012 Aug;5(4):247-51. Epub 2012 Aug 1.

PMID:
22937176
[PubMed]
Free PMC Article
2.

Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.

Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN.

Mod Pathol. 2005 Jan;18(1):143-52.

PMID:
15297858
[PubMed - indexed for MEDLINE]
Free Article
3.

Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability.

Miyamoto N, Yamamoto H, Taniguchi H, Miyamoto C, Oki M, Adachi Y, Imai K, Shinomura Y.

Cancer Lett. 2007 Aug 28;254(1):42-53. Epub 2007 Mar 19.

PMID:
17374440
[PubMed - indexed for MEDLINE]
4.

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.

Yamamoto S, Tsuda H, Takano M, Tamai S, Matsubara O.

Mod Pathol. 2012 Apr;25(4):615-24. doi: 10.1038/modpathol.2011.189. Epub 2011 Dec 9.

PMID:
22157930
[PubMed - indexed for MEDLINE]
Free Article
5.

Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Kim HJ, Park CI, Park BW, Lee HD, Jung WH.

Yonsei Med J. 2006 Jun 30;47(3):333-42.

PMID:
16807982
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET.

J Natl Cancer Inst. 2002 Jul 3;94(13):990-1000.

PMID:
12096084
[PubMed - indexed for MEDLINE]
Free Article
7.

Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.

Loges S, Clausen H, Reichelt U, Bubenheim M, Erbersdobler A, Schurr P, Yekebas E, Schuch G, Izbicki J, Pantel K, Bokemeyer C, Fiedler W.

Clin Cancer Res. 2007 Jan 1;13(1):76-80.

PMID:
17200341
[PubMed - indexed for MEDLINE]
Free Article
8.

Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.

Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder BA, Piver MS.

J Natl Cancer Inst. 2000 Jul 5;92(13):1088-91.

PMID:
10880552
[PubMed - indexed for MEDLINE]
Free Article
9.

The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.

Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.

J Pathol. 2003 Jun;200(2):183-94.

PMID:
12754739
[PubMed - indexed for MEDLINE]
10.

beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.

Moreno-Bueno G, Gamallo C, Pérez-Gallego L, de Mora JC, Suárez A, Palacios J.

Diagn Mol Pathol. 2001 Jun;10(2):116-22.

PMID:
11385321
[PubMed - indexed for MEDLINE]
11.

BRCA1 gene mutations in sporadic ovarian carcinomas: detection by PCR and reverse allele-specific oligonucleotide hybridization.

Tong D, Stimpfl M, Reinthaller A, Vavra N, Müllauer-Ertl S, Leodolter S, Zeillinger R.

Clin Chem. 1999 Jul;45(7):976-81.

PMID:
10388472
[PubMed - indexed for MEDLINE]
Free Article
12.

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma.

McAlpine JN, Porter H, Köbel M, Nelson BH, Prentice LM, Kalloger SE, Senz J, Milne K, Ding J, Shah SP, Huntsman DG, Gilks CB.

Mod Pathol. 2012 May;25(5):740-50. doi: 10.1038/modpathol.2011.211. Epub 2012 Jan 27.

PMID:
22282309
[PubMed - indexed for MEDLINE]
Free Article
13.

Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A.

Talbot SG, O-charoenrat P, Sarkaria IS, Ghossein R, Reddy P, Ngai I, Cordeiro CN, Wong RJ, Kris MG, Rusch VW, Singh B.

Ann Surg Oncol. 2004 May;11(5):530-4.

PMID:
15123463
[PubMed - indexed for MEDLINE]
14.

No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers.

Aghmesheh M, Nesland JM, Kaern J, Dorum A, Edwards L, Byth K, Friedlander M, Jackson P, Tucker KM, Russell PJ.

Gynecol Oncol. 2004 Dec;95(3):430-6.

PMID:
15581943
[PubMed - indexed for MEDLINE]
15.

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.

Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI; Tumor and Angiogenesis Research Group.

Cancer. 2002 Sep 1;95(5):1055-63.

PMID:
12209691
[PubMed - indexed for MEDLINE]
Free Article
16.

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

Singer G, Stöhr R, Cope L, Dehari R, Hartmann A, Cao DF, Wang TL, Kurman RJ, Shih IeM.

Am J Surg Pathol. 2005 Feb;29(2):218-24.

PMID:
15644779
[PubMed - indexed for MEDLINE]
17.

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.

Swisher EM, Gonzalez RM, Taniguchi T, Garcia RL, Walsh T, Goff BA, Welcsh P.

Mol Cancer. 2009 Jul 14;8:48. doi: 10.1186/1476-4598-8-48.

PMID:
19602291
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.

Tsuchiya T, Nakahama K, Asakawa Y, Maemura T, Tanaka M, Takeda S, Morita M, Morita I.

Gynecol Endocrinol. 2009 Feb;25(2):104-9. doi: 10.1080/09513590802549841.

PMID:
19253105
[PubMed - indexed for MEDLINE]
19.

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R.

Cancer. 2005 Dec 15;104(12):2807-16.

PMID:
16284991
[PubMed - indexed for MEDLINE]
Free Article
20.

VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis.

Bandoh N, Hayashi T, Takahara M, Kishibe K, Ogino T, Katayama A, Imada M, Nonaka S, Harabuchi Y.

Cancer Lett. 2004 May 28;208(2):215-25.

PMID:
15142681
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk